-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Vitro Biopharma, Inc. quarterly/annual Depreciation history and growth rate from Q4 2021 to Q4 2024.
- Vitro Biopharma, Inc. Depreciation for the quarter ending January 31, 2025 was $37.4K, a 14% decline year-over-year.
- Vitro Biopharma, Inc. Depreciation for the twelve months ending January 31, 2025 was $175K, a 10.5% increase year-over-year.
- Vitro Biopharma, Inc. annual Depreciation for 2024 was $181K, a 18.2% increase from 2023.
- Vitro Biopharma, Inc. annual Depreciation for 2023 was $153K, a 6.58% decline from 2022.
- Vitro Biopharma, Inc. annual Depreciation for 2022 was $164K.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)